Investing.com – Clearside Biomedical (NASDAQ: CLSD) reported first quarter EPS of $-0.110, $0.02 worse than the analyst estimate of $-0.090. Revenue for the quarter came in at $2.33M versus the consensus estimate of $100K.
Clearside Biomedical’s stock price closed at $0.85. It is down -20.190% in the last 3 months and down -34.810% in the last 12 months.
Clearside Biomedical saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Clearside Biomedical’s stock price’s past reactions to earnings here.
Check out Clearside Biomedical’s recent earnings performance, and Clearside Biomedical’s financials here.
